openPR Logo
Press release

Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market Driver: A Major Catalyst in the Evolution of the Gastroesophageal Reflux Disease (GERD) Market in 2025

03-11-2025 08:19 AM CET | Health & Medicine

Press release from: The Business Research Company

Gastroesophageal Reflux Disease GERD Market Size

Gastroesophageal Reflux Disease GERD Market Size

What market dynamics are playing a key role in accelerating the growth of the gastroesophageal reflux disease (gerd) market?
The increase in esophageal diseases is anticipated to fuel the gastroesophageal reflux disease (GERD) market's expansion. Such diseases affect the esophagus, the muscle tube that connects the mouth to the stomach, and their treatment focuses on reducing symptoms, enhancing quality of life, and averting complications for those affected by GERD. For example, the American Cancer Society reported in January 2023 that approximately 21,560 new cases of esophageal cancer are identified annually in the US, resulting in 16,120 deaths. As a result, the increasing prevalence of esophageal diseases underpins the growing GERD market. Alcohol Consumption's Effect on the Gastroesophageal Reflux Disease (GERD) Market Growth

Get Your Gastroesophageal Reflux Disease (GERD) Market Report Here:
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

How will the growth rate of the gastroesophageal reflux disease (gerd) market shape industry trends by 2034?
In recent times, there has been a slight increase in the size of the gastroesophageal reflux disease (GERD) market. The growth is expected to rise from a value of $5.25 billion in 2024 to about $5.35 billion by 2025, indicating a compound annual growth rate (CAGR) of 2.0%. Factors contributing to this growth in the past include changes in lifestyle and dietary habits, an obesity epidemic, heightened knowledge about GERD treatments, the expansion of the pharmaceutical industry worldwide, and financial investments in GERD treatments.

In the coming years, the market for gastroesophageal reflux disease (GERD) is projected to expand steadily. By 2029, it's estimated to reach $5.94 billion, with a compound annual growth rate (CAGR) of 2.7%. Important growth factors during the forecast period include the aging of the population, elevating healthcare expenditure, the advent of biomarkers, the increased volume of GERD screening programs, rising heartburn prevalence, and the escalating demand for medical devices. Trending advancements in diagnostics and surgical procedures, the progression of specialized therapies, and the implementation of telehealth services contribute to the major market trends to keep an eye on in the forecast duration.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp

What new trends are reshaping the gastroesophageal reflux disease (gerd) market and its opportunities?
Leading players in the gastroesophageal reflux disease (GERD) market are concentrating on launching novel GE reflux disease treatment tools to strengthen their market presence. For example, Laborie Medical Technologies, a prominent medical technology firm based in the US, rolled out the innovative alpHaONE wireless pH-capsule reflux testing diagnostic system specifically for GERD diagnosis in April 2023. This system allows up to 96 hours of data monitoring and boasts a sleek design, larger buttons, and a foolproof capsule delivery system. Furthermore, it includes a software application equipped with a virtual instruction module and customizable symptom buttons for an enhanced user experience.

Which primary segments of the gastroesophageal reflux disease (gerd) market are driving growth and industry transformations?
The gastroesophageal reflux disease (GERD) market covered in this report is segmented -

1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics

Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12917

Which geographical regions are pioneering growth in the gastroesophageal reflux disease (gerd) market?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the gastroesophageal reflux disease (gerd) market landscape?
Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp

What Is Covered In The Gastroesophageal Reflux Disease (GERD) Global Market Report?

• Market Size Forecast: Examine the gastroesophageal reflux disease (gerd) market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the gastroesophageal reflux disease (gerd) market for a structured understanding.
• Key Players Overview: Analyze major players in the gastroesophageal reflux disease (gerd) market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gastroesophageal reflux disease (gerd) market.
• Segment Contributions: Evaluate how different segments drive overall growth in the gastroesophageal reflux disease (gerd) market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gastroesophageal reflux disease (gerd) market.
• Industry Challenges: Identify potential risks and obstacles affecting the gastroesophageal reflux disease (gerd) market.
• Competitive Landscape: Review strategic developments in the gastroesophageal reflux disease (gerd) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market Driver: A Major Catalyst in the Evolution of the Gastroesophageal Reflux Disease (GERD) Market in 2025 here

News-ID: 3909047 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for GERD

GERD Explained: Causes, Symptoms, and Risks
GERD (gastroesophageal reflux disease) happens when the lower esophageal sphincter (LES)-the valve between the stomach and esophagus-doesn't close properly, allowing acid to flow back up. This can cause heartburn, regurgitation, sour taste, chest/throat burning, hoarseness, and trouble swallowing. Over time, ongoing reflux may lead to esophagitis, ulcers, scarring/stricture, and Barrett's esophagus. Understanding GERD: Why Symptoms Persist GERD occurs when the LES does not close properly, allowing stomach acid and digestive contents to
Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal R …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastroesophageal Reflux Disease (GERD) Market Size By 2025? The market encompassing gastroesophageal reflux disease (GERD) has experienced a slight expansion lately, projected to advance from its 2024 valuation of $5.25 billion to $5.33 billion by 2025, reflecting a compound annual growth rate of 1.6%; this
Gastroesophageal Reflux Disease (GERD) Devices Market Insights and Future Outloo …
Introduction Gastroesophageal Reflux Disease (GERD) is a chronic condition where stomach contents flow back into the esophagus, causing symptoms such as heartburn, regurgitation, chest pain, and, in severe cases, esophagitis or Barrett's esophagus. While medications like proton pump inhibitors (PPIs) are widely used for management, a growing number of patients experience refractory GERD, where pharmacological treatments fail to provide relief. This has accelerated demand for GERD devices, which include endoscopic therapies, implantable
Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal R …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Through 2025? The market for gastroesophageal reflux disease (GERD) has seen a slight expansion in recent years. It is projected to increase from $5.25 billion in 2024 to $5.35 billion in 2025, marking a compound annual growth
Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023
WiseGuyReports.Com Publish a New Market Research Report On –“ Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023”. Gerd & Nerd TreatmIndustry 2019 Description:- In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry. The Gastroesophageal Reflux